Johnson & Johnson is just one of the pharmaceutical companies that will be carrying out a human vaccine HIV test. The company has already completed animal studies and it has established the safety of the vaccine. It will now have to work towards proving the vaccine’s effectiveness. Results from the trial are anticipated in 2023 but it isn’t the only experiment currently underway. A HIV vaccine trial is already taking place in Africa. The African study involves female volunteers due to the disproportionately high infection risk women in many African countries face.

A new academic analysis shows that the size of the population at risk of a HIV infection in Singapore is much larger than initially estimated. According to the National University of Singapore researchers, there are over 210,000 men engaging in sexual contact with other men – an activity that puts them at a high risk of infection. There are three additional at-risk groups – the male clients of female sex workers, the sex workers themselves and intravenous drug users.

HIV-positive individuals can lead long and productive lives nowadays. Miguel or the Lisbon Patient is the living proof of that claim. Diagnosed with early-stage AIDS when he was 84, Miguel has just celebrated his 100th birthday. While he does experience some minor age-related problems, Miguel is perfectly healthy and HIV is undetectable in his body. The doctors treating Miguel have decided to share his story in order to inspire HIV-positive individuals and help them seek treatment as soon as possible.

Medicine has accomplished a lot in terms of treating HIV-positive individuals. HIV PEP, HIV PrEP and antiretroviral medications could make the viral load virtually undetectable. Regardless of medical advances, however, HIV acceptance in Singapore remains low. Even medical professionals contribute to the perpetuation of the stigma. Because of the negative attitudes, the number of people who get tested and who start receiving treatment early enough after an infection remains low.